Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Mutations in chronic myelomonocytic leukemia and their prognostic relevance
Jinli Jian, Yufeng Qiao, Y. Li, et al.
Clinical & Translational Oncology (2021) Vol. 23, Iss. 9, pp. 1731-1742
Closed Access | Times Cited: 17

Showing 17 citing articles:

Chronic Myelomonocytic leukemia: 2020 update on diagnosis, risk stratification and management
Mrinal M. Patnaik, Ayalew Tefferi
American Journal of Hematology (2019) Vol. 95, Iss. 1, pp. 97-115
Open Access | Times Cited: 119
Diagnostic and therapeutic pitfalls in NPM1-mutated AML: notes from the field
Brunangelo Falini, Sofia Sciabolacci, Lorenza Falini, et al.
Leukemia (2021) Vol. 35, Iss. 11, pp. 3113-3126
Open Access | Times Cited: 30
The Hippo signaling pathway in leukemia: function, interaction, and carcinogenesis
Negar Noorbakhsh, Bentolhoda Hayatmoghadam, Marzieh Jamali, et al.
Cancer Cell International (2021) Vol. 21, Iss. 1
Open Access | Times Cited: 20
Mutational landscape of chronic myelomonocytic leukemia in Chinese patients
Yanbo Nie, Liang Shao, Hong Zhang, et al.
Experimental Hematology and Oncology (2022) Vol. 11, Iss. 1
Open Access | Times Cited: 10
Real-World Data on Chronic Myelomonocytic Leukemia: Clinical and Molecular Characteristics, Treatment, Emerging Drugs, and Patient Outcomes
Sandra Castaño‐Díez, Mònica López‐Guerra, Cristina Bosch-Castañeda, et al.
Cancers (2022) Vol. 14, Iss. 17, pp. 4107-4107
Open Access | Times Cited: 10
Plasmacytoid Dendritic Cell Dermatosis Associated to Myeloproliferative/Myelodysplastic Neoplasms
Salma Machán, Juan Manuel Alonso‐Domínguez, F. Javier Sánchez García, et al.
The American Journal of Surgical Pathology (2022) Vol. 46, Iss. 12, pp. 1623-1632
Closed Access | Times Cited: 10
Leukemia cutis and anterior uveitis associated with chronic myelomonocytic leukemia
Kamran Harper, Vanessa Mutch, Jordan Philip Safran, et al.
JAAD Case Reports (2024) Vol. 52, pp. 21-24
Open Access | Times Cited: 1
Prognostic Implication of Early Minimal Residual Disease Evaluation in Patients with Chronic Myelomonocytic Leukemia
Lulu Wang, Rongrong Chen, Li Li, et al.
Research Square (Research Square) (2022)
Open Access | Times Cited: 3
Recent Advances in the Molecular Pathogenesis and Diagnosis of Chronic Myelomonocytic Leukemia
Michele K. Anderson, Rajeswari Jayakumar
Advances in Molecular Pathology (2024) Vol. 7, Iss. 1, pp. 63-75
Closed Access
Molecular landscape and clinical outcome of SRSF2 / TET2 Co-mutated myeloid neoplasms
Samuel G. Cockey, Hailing Zhang, Mohammed Hussaini, et al.
Leukemia & lymphoma/Leukemia and lymphoma (2024), pp. 1-10
Closed Access
Integrating multi-omics methods for personalized treatment of refractory chronic myelomonocytic leukemia with NRAS and TET2 mutations
Chuandong Hou, Bo Yang, Yue Wang, et al.
Cancer Pathogenesis and Therapy (2024) Vol. 3, Iss. 2, pp. 173-175
Open Access
Clinical, Histopathological and Molecular Spectrum of Cutaneous Lesions in Myelodysplastic Syndrome and Myeloproliferative Neoplasms (MDS/MPN): A Review and A Proposed Classification
Lucía Prieto‐Torres, Luís Requena, Socorro María Rodríguez‐Pinilla
(2023)
Open Access | Times Cited: 1
Clinical, Histopathological and Molecular Spectrum of Cutaneous Lesions in Myelodysplastic Syndrome and Myeloproliferative Neoplasms (MDS/MPN): An Integrative Review
Lucía Prieto‐Torres, Luís Requena, Socorro María Rodríguez‐Pinilla
Cancers (2023) Vol. 15, Iss. 24, pp. 5888-5888
Open Access | Times Cited: 1
Treatment Outcomes and Prognostic Factors in 66 Patients with Chronic Myelomonocytic Leukemia (CMML) in a Single Center
Chao Wang, Zhiqiong Wang, Fankai Meng, et al.
International Journal of General Medicine (2022) Vol. Volume 15, pp. 7843-7854
Open Access | Times Cited: 2
Philadelphia Negative MPNs, MDS/MPNs and MDS in the Context of Recent WHO Changes and Inclusion of Molecular Signatures into Prognostic Tools: A Single Centre Experience
Neha Singh, Sujeet Kumar, Avinash Gupta
Asian Pacific Journal of Cancer Biology (2023) Vol. 8, Iss. 1, pp. 5-11
Open Access
Acute Myeloid Leukemia Transformed from Aplastic Anemia following Anti-thymocyte Globulin Therapy: A Case Report with Clinicopathologic and Molecular Findings
Qurat ul Abedin, Saima Siddiqui, Jawad Hassan
National Journal of Health Sciences (2022) Vol. 7, Iss. 4, pp. 193-195
Open Access
A Pharmacokinetic/Pharmacodynamic Model of the Action of Hypomethylating Agents in Chronic Myelomonocytic Leukaemia
Robert J. Jackson, Tomas Radivoyevitch
Medical Research Archives (2021) Vol. 9, Iss. 10
Open Access
Page 1

Scroll to top